{"cik":"0000939767","ticker":"EXEL","name":"EXELIXIS, INC.","sic_code":"2836","sic_description":"Biological Products, (No Diagnostic Substances)","exchange":"Nasdaq","state_of_incorporation":"DE","fiscal_year_end":"0101","first_filing_date":"2026-05-14","last_filing_date":"2026-09-11","url":"/sec/cik-0000939767","insider_summary":{"total_transactions":22,"unique_insiders":10,"latest_transaction":"2026-06-01"},"recent_filings":[{"accession_number":"0000939767-26-000108","form_type":"8-K","form_type_family":"current","doc_date":"2026-09-11","title":"8-K — EXELIXIS, INC. — 2026-09-11","url_slug":"/sec/cik-0000939767/8-k/0000939767-26-000108","edgar_url":"https://www.sec.gov/Archives/edgar/data/939767/0000939767-26-000108-index.html"},{"accession_number":"0001950047-26-005335","form_type":"144","form_type_family":"other","doc_date":"2026-06-01","title":"144 — WYSZOMIERSKI JACK L — 2026-06-01","url_slug":"/sec/cik-0001023225/144/0001950047-26-005335","edgar_url":"https://www.sec.gov/Archives/edgar/data/939767/0001950047-26-005335-index.html"}],"related_endpoints":{"profile":"/sec/EXEL/profile","timeline":"/sec/EXEL/timeline","peers":"/sec/EXEL/peers","insider_pulse":"/sec/EXEL/insider-pulse","insider_summary":"/sec/EXEL/insider-summary","insider_transactions":"/sec/EXEL/insider-transactions","form144":"/sec/EXEL/form144","holdings_as_filer":"/sec/EXEL/holdings","financial_facts":"/sec/EXEL/financial-facts","derivatives":"/sec/EXEL/derivatives","officers":"/sec/EXEL/officers","insider_network":"/sec/EXEL/insider-network","risk_flags":"/sec/EXEL/risk-flags","filings":"/sec/EXEL/filings","cross_topic_dossier":"/api/v1/dossier?ticker=EXEL"}}